REPLY:
Mei‐Hsuan Lee, Yi‐Hsiang Huang, Jill Koshiol – 7 July 2021
Dietary Risks for Liver Mortality in NAFLD: Global Burden of Disease Data
James M. Paik, Seema Mir, Saleh A. Alqahtani, Youssef Younossi, Janus P. Ong, Zobair M. Younossi – 7 July 2021 – Nonalcoholic fatty liver disease (NAFLD) is a common but complex chronic liver disease, driven by environmental and genetic factors. We assessed metabolic and dietary risk factor associations with NAFLD liver mortality using the Global Burden of Disease (GBD) 2017 data. NAFLD liver deaths were calculated (per 100,000) as age‐standardized rates (ASRs) from 195 countries and territories (21 GBD regions; 7 GBD superregions).
PRO‐C3, a Serological Marker of Fibrosis, During Childhood and Correlations With Fibrosis in Pediatric NAFLD
Catherine C. Cohen, Eduardo Castillo‐Leon, Alton B. Farris, Shelley A. Caltharp, Rebecca L. Cleeton, Elizabeth M. Sinclair, Diane E. Shevell, Morten A. Karsdal, Mette Juul Fisker Nielsen, Diana J. Leeming, Miriam B. Vos – 7 July 2021 – Nonalcoholic fatty liver disease (NAFLD) is a common chronic liver disease in children and may lead to cirrhosis requiring liver transplant. Thus, prompt diagnosis of advanced fibrosis is essential.
Global Microbiota‐Dependent Histone Acetylation Patterns Are Irreversible and Independent of Short Chain Fatty Acids
Yedidya Saiman, Ting‐Chin David Shen, Peder J. Lund, Victoria M. Gershuni, Cholsoon Jang, Shivali Patel, Sunhee Jung, Emma E. Furth, Elliot S. Friedman, Lillian Chau, Benjamin A. Garcia, Gary D. Wu – 6 July 2021
Hypothermic Oxygenated Machine Perfusion Protects From Cholangiopathy in Donation after Circulatory Death Liver Transplantation
Femke H. C. Goeij, Andrea Schlegel, Paolo Muiesan, James V. Guarrera, Philipp Dutkowski – 6 July 2021
Malnutrition, Frailty, and Sarcopenia in Patients With Cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases
Jennifer C. Lai, Puneeta Tandon, William Bernal, Elliot B. Tapper, Udeme Ekong, Srinivasan Dasarathy, Elizabeth J. Carey – 6 July 2021
Hepatocellular Carcinoma Prevention by Aspirin: Are Platelets the Link?
Hans Dieter Nischalke, Alexandra Klüners, Jacob Nattermann, Thomas Berg, Christian P. Strassburg, Philipp Lutz – 6 July 2021
Dietary N‐Nitroso Compounds and Risk of Hepatocellular Carcinoma: A USA‐Based Study
Jiali Zheng, Carrie R. Daniel, Rikita I. Hatia, Janice Stuff, Ahmed A. Abdelhakeem, Asif Rashid, Yun Shin Chun, Prasun K. Jalal, Ahmed O. Kaseb, Donghui Li, Manal M. Hassan – 6 July 2021
A Mammalian Target of Rapamycin‐Perilipin 3 (mTORC1‐Plin3) Pathway is essential to Activate Lipophagy and Protects Against Hepatosteatosis
Marina Garcia‐Macia, Adrián Santos‐Ledo, Jack Leslie, Hannah L. Paish, Amy L. Collins, Rebecca S. Scott, Abigail Watson, Rachel A. Burgoyne, Steve White, Jeremy French, John Hammond, Lee A. Borthwick, Jelena Mann, Juan P. Bolaños, Viktor I. Korolchuk, Fiona Oakley, Derek A. Mann – 6 July 2021
Fatty Acid Synthase–Suppressor Screening Identifies Sorting Nexin 8 as a Therapeutic Target for NAFLD
Yufeng Hu, Wenzhi He, Yongping Huang, Hui Xiang, Juan Guo, Yan Che, Xu Cheng, Fengjiao Hu, Manli Hu, Tengfei Ma, Jie Yu, Han Tian, Song Tian, Yan‐Xiao Ji, Peng Zhang, Zhi‐Gang She, Xiao‐Jing Zhang, Zan Huang, Juan Yang, Hongliang Li – 6 July 2021